Documents
Application Sponsors
NDA 214826 | Almatica Pharma, LLC | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Prescription | 004 |
Application Products
001 | CAPSULE, EXTENDED RELEASE;ORAL | 1MG | 0 | LOREEV XR | LORAZEPAM |
002 | CAPSULE, EXTENDED RELEASE;ORAL | 2MG | 0 | LOREEV XR | LORAZEPAM |
003 | CAPSULE, EXTENDED RELEASE; ORAL | 3MG | 0 | LOREEV XR | LORAZEPAM |
004 | CAPSULE, EXTENDED RELEASE;ORAL | 1.5MG | 1 | LOREEV XR | LORAZEPAM |
FDA Submissions
TYPE 3; Type 3 - New Dosage Form | ORIG | 1 | AP | 2021-08-27 | STANDARD |
LABELING; Labeling | SUPPL | 3 | AP | 2023-01-13 | STANDARD |
Submissions Property Types
CDER Filings
Almatica Pharma, LLC
cder:Array
(
[0] => Array
(
[ApplNo] => 214826
[companyName] => Almatica Pharma, LLC
[docInserts] => ["",""]
[products] => [{"drugName":"LOREEV XR","activeIngredients":"LORAZEPAM","strength":"1MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"LOREEV XR","activeIngredients":"LORAZEPAM","strength":"2MG","dosageForm":"CAPSULE, EXTENDED RELEASE;ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"LOREEV XR","activeIngredients":"LORAZEPAM","strength":"3MG","dosageForm":"CAPSULE, EXTENDED RELEASE; ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"08\/27\/2021","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 3 - New Dosage Form","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2021\\\/214826Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2021-08-27
)
)